These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 21921264)
1. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264 [TBL] [Abstract][Full Text] [Related]
2. Modeling myocardial growth and hypertrophy in engineered heart muscle. Tiburcy M; Zimmermann WH Trends Cardiovasc Med; 2014 Jan; 24(1):7-13. PubMed ID: 23953977 [TBL] [Abstract][Full Text] [Related]
3. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. Hirt MN; Boeddinghaus J; Mitchell A; Schaaf S; Börnchen C; Müller C; Schulz H; Hubner N; Stenzig J; Stoehr A; Neuber C; Eder A; Luther PK; Hansen A; Eschenhagen T J Mol Cell Cardiol; 2014 Sep; 74():151-61. PubMed ID: 24852842 [TBL] [Abstract][Full Text] [Related]
4. Engineering an in vitro organotypic model for studying cardiac hypertrophy. Jain A; Hasan J; Desingu PA; Sundaresan NR; Chatterjee K Colloids Surf B Biointerfaces; 2018 May; 165():355-362. PubMed ID: 29518684 [TBL] [Abstract][Full Text] [Related]
5. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function. Jackman C; Li H; Bursac N Acta Biomater; 2018 Sep; 78():98-110. PubMed ID: 30086384 [TBL] [Abstract][Full Text] [Related]
6. Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes. Sheehy SP; Grosberg A; Qin P; Behm DJ; Ferrier JP; Eagleson MA; Nesmith AP; Krull D; Falls JG; Campbell PH; McCain ML; Willette RN; Hu E; Parker KK Exp Biol Med (Maywood); 2017 Nov; 242(17):1643-1656. PubMed ID: 28343439 [TBL] [Abstract][Full Text] [Related]
7. PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue. Vantler M; Karikkineth BC; Naito H; Tiburcy M; Didié M; Nose M; Rosenkranz S; Zimmermann WH J Mol Cell Cardiol; 2010 Jun; 48(6):1316-23. PubMed ID: 20307544 [TBL] [Abstract][Full Text] [Related]
8. Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling. Shen S; Sewanan LR; Campbell SG J Mol Cell Cardiol; 2021 Sep; 158():11-25. PubMed ID: 33992697 [TBL] [Abstract][Full Text] [Related]
9. Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. Leonard A; Bertero A; Powers JD; Beussman KM; Bhandari S; Regnier M; Murry CE; Sniadecki NJ J Mol Cell Cardiol; 2018 May; 118():147-158. PubMed ID: 29604261 [TBL] [Abstract][Full Text] [Related]
10. Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro. Katare RG; Ando M; Kakinuma Y; Sato T PLoS One; 2010 Feb; 5(2):e9275. PubMed ID: 20174664 [TBL] [Abstract][Full Text] [Related]
11. Tissue engineering of a differentiated cardiac muscle construct. Zimmermann WH; Schneiderbanger K; Schubert P; Didié M; Münzel F; Heubach JF; Kostin S; Neuhuber WL; Eschenhagen T Circ Res; 2002 Feb; 90(2):223-30. PubMed ID: 11834716 [TBL] [Abstract][Full Text] [Related]
12. Decellularized extracellular matrix bioinks and the external stimuli to enhance cardiac tissue development in vitro. Das S; Kim SW; Choi YJ; Lee S; Lee SH; Kong JS; Park HJ; Cho DW; Jang J Acta Biomater; 2019 Sep; 95():188-200. PubMed ID: 30986526 [TBL] [Abstract][Full Text] [Related]
13. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833 [TBL] [Abstract][Full Text] [Related]
14. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue. Li Y; Asfour H; Bursac N Acta Biomater; 2017 Jun; 55():120-130. PubMed ID: 28455218 [TBL] [Abstract][Full Text] [Related]
16. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518 [TBL] [Abstract][Full Text] [Related]
17. Development of a biological ventricular assist device: preliminary data from a small animal model. Yildirim Y; Naito H; Didié M; Karikkineth BC; Biermann D; Eschenhagen T; Zimmermann WH Circulation; 2007 Sep; 116(11 Suppl):I16-23. PubMed ID: 17846298 [TBL] [Abstract][Full Text] [Related]
18. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes. Madsen A; Krause J; Höppner G; Hirt MN; Tan WLW; Lim I; Hansen A; Nikolaev VO; Foo RSY; Eschenhagen T; Stenzig J J Mol Cell Cardiol; 2021 May; 154():115-123. PubMed ID: 33582159 [TBL] [Abstract][Full Text] [Related]